(a) The purpose of this part is to establish approval requirements for proposed sites for stationary power and testing reactors subject to part 50 or part 52 of this chapter.
The FDA Modernization Act of 1977 (Section 121) requires the FDA to establish approval procedures and cGMP for PET drugs.
Section 204 has also been amended to clarify that, in the event a stockholder vote is scheduled for a ratification of a defective corporate act that itself involved the establishment of a record date, the notice that is required must also be sent to all holders of valid or putative stock as of the record date originally established for approval of that defective corporate act.
But "on balance, the guidelines are a vast improvement over the draft guidelines," says Eggan. "The establishment of the registry is an important improvement, as is the clearly established route to approval for lines that need 'grandfathering.'" Stem cell researcher Sean Morrison of the University of Michigan Medical School in Ann Arbor lauds NIH for "a really good job".
The Food and Drug Administration establishes labeling format, requires approval for nutrient content claims and requires that all dietary supplement health claims be pre-authorized.
Marielle Weintraub is president of the U.S. Hemp Authority, an organization that established a seal of approval for high-quality CBD products.
Australia and New Zealand Banking Group said Wednesday its was seeking regulatory approval for establishing a wholly owned locally incorporated bank subsidiary in China and a new rural bank in western China.
President Obama delivered his most forceful push for action on global warming on Tuesday, declaring that his administration would impose tighter pollution controls on coal- and gas-fired utilities and establish strict conditions for approval of the proposed Keystone XL pipeline.
And it should establish a process for approval of investigations into unlawful conduct that "may incidentally result in political intelligence," he said.
In principle, the value of the disease-based communities should be acknowledged and regulatory/reimbursement bodies should view them as active partners in establishing criteria for approval of new treatments in rare cancers.
In fact, the Japanese government has recently committed to establish a new approval process for regenerative medicine products focused on accelerating approval timelines.
